Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-28T18:02:06.168Z Has data issue: false hasContentIssue false

Problematic drug use, ageing and older people: trends in the age of drug users in northwest England

Published online by Cambridge University Press:  25 October 2007

CARYL M. BEYNON*
Affiliation:
Centre for Public Health, Liverpool John Moores University, Liverpool, UK.
JIM McVEIGH
Affiliation:
Centre for Public Health, Liverpool John Moores University, Liverpool, UK.
BRENDA ROE
Affiliation:
Faculty of Health and Applied Social Sciences, Liverpool John Moores University, Liverpool, UK.
*
Address for correspondence: Caryl M. Beynon, Centre for Public Health, Faculty of Health and Applied Social Sciences, Liverpool John Moores University, Castle House, North Street, Liverpool, L3 2AY, UK. E-mail: c.m.beynon@ljmu.ac.uk

Abstract

In the United Kingdom (UK) and elsewhere, little is known about problematic drug use among older people (defined here as aged 50–74 years), either because few older drug users exist or because they represent a ‘hidden’ population. In this paper, we show that the average age of drug users in contact with treatment services and agency-based syringe exchange programmes (SEPs) in the counties of Cheshire and Merseyside in northwest England is rising. Between 1998 and 2004–05, the number of older male drug users in treatment increased from 80 to 310, and the number of older females rose from 46 to 117. Consequently, the median age rose from 30.8 years in 1998 to 34.9 years in 2004–05. Similarly, between 1992 and 2004, the number of older injectors accessing SEPs increased from three to 65 men and from one to nine women. The median age of SEP attenders was 27.0 years in 1992 and 34.9 years in 2004. Drug use amongst older people is associated with poor physical and psychological health and longer hospital stays. The future cost of the ageing of drug users may be considerable. Detailed research is needed to identify the characteristics and health needs of this vulnerable population.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beynon, C., Bellis, M. A., Millar, T., Meier, P., Thomson, R. and Mackway Jones, K. 2001 a. Hidden need for drug treatment services: measuring levels of problematic drug use in the North West of England. Journal of Public Health Medicine, 23, 4, 286–91.CrossRefGoogle ScholarPubMed
Beynon, C., Birtles, R. L. and Bellis, M. A. 2001 b. Drug Services in Merseyside and Cheshire 2000/01: Prevalence and Outcomes. Centre for Public Health, Liverpool John Moores University, Liverpool.Google Scholar
Beynon, C. M. and McVeigh, J. 2007. The role of substance use in non-drug related deaths: a cross-sectional study of drug treatment clients in the North West of England. Journal of Substance Use, 12, 1, 3947.CrossRefGoogle Scholar
Boys, A., Marsden, J., Griffiths, P., Fountain, J., Stillwell, G. and Strang, J. 1999. Substance use amongst young people: the relationship between perceived functions and intentions. Addiction, 94, 7, 1043–50.CrossRefGoogle Scholar
Crabbe, T. and Donmall, M. 1996. The optimal size for attributor for use with the University of Manchester Drug Misuse Database. Addiction, 91, 10, 1547–50.CrossRefGoogle ScholarPubMed
Cumming, R. G. and Le Couteur, D. G. 2003. Benzodiazepines and risk of hip fractures in older people. CNS Drugs, 17, 11, 825–37.CrossRefGoogle ScholarPubMed
Dean, A. G., Dean, J. A., Burton, A. H. and Dicker, R. C. 1999. EpiInfo, Version 6: A Word Processing, Database and Statistics Program for Epidemiology on Microcomputers. Centres for Disease Control, Atlanta, Georgia.Google Scholar
Dent, O. F., Grayson, D. A., Waite, L. M., Cullen, J. S., Creasey, H. and Broe, G. A. 2000. Alcohol consumption in a community sample of old people. Australian and New Zealand Journal of Public Health, 24, 3, 323–6.CrossRefGoogle Scholar
Donmall, M. and Jones, A. 2004. Healthcare Commission: Data Quality and Process. Document 2.01, National Drug Evidence Centre, University of Manchester, Manchester. Available on line at http://www.nta.nhs.uk/programme/national/Data_Quality_Report.pdf [Accessed 11 April 2006].Google Scholar
Drug Strategy Directorate 1998. Tackling Drugs to Build a Better Britain: The Government's Ten-Year Strategy for Tackling Drugs Misuse. Stationery Office, London.Google Scholar
Drug Strategy Directorate 2002. Updated Drug Strategy 2002. Stationery Office, London.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction 2005. Annual Report 2005. Office for Official Publications of the European Communities, Luxembourg.Google Scholar
Gilhooly, M. L. M. 2005. Reduced drinking with age: is it normal? Addiction Research and Therapy, 13, 3, 267–80.CrossRefGoogle Scholar
Gossop, M., Trakada, K., Stewart, D. and Witton, J. 2006. Levels of Conviction Following Drug Treatment: Linking Data from the National Treatment Outcome Research Study and the Offenders' Index. Findings 275, Home Office, London.Google Scholar
Gfroerer, J., Penne, M., Pemberton, M. and Folsom, R. 2003. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug and Alcohol Dependence, 69, 2, 127–35.CrossRefGoogle ScholarPubMed
Halkitis, P. N., Fischgrund, B. N. and Parsons, J. T. 2005. Explanations for methamphetamine use among gay and bisexual men in New York City. Substance Use and Misuse, 40, 9–10, 1331–45.CrossRefGoogle ScholarPubMed
Hser, Y. I., Gelberg, L., Hoffman, V., Grella, C. E., McCarthy, W. and Anglin, M. D. 2004. Health conditions among aging narcotic addicts: medical examination results. Journal of Behavioural Medicine, 27, 6, 607–22.CrossRefGoogle ScholarPubMed
House of Lords 2005. Ageing: Scientific Aspects. 5th Report, Volume I, House of Lords Scientific and Technology Committee, Stationery Office, London.Google Scholar
Johnson, W. A. and Sterk, C. E. 2003. Late-onset crack users: an emergent HIV risk group. Journal of Acquired Immune Deficiency Syndromes, 33 (supplement 2), S22932.CrossRefGoogle ScholarPubMed
Levy, J. A. and Anderson, T. 2005. The drug career of the older injector. Addiction Research and Theory, 13, 3, 245–58.CrossRefGoogle Scholar
McVeigh, J., Beynon, C. and Bellis, M. A. 2003. New challenges for agency based syringe exchange schemes: analysis of 11 years of data (1991–2001) in Merseyside and Cheshire, United Kingdom. International Journal of Drug Policy, 14, 5–6, 399405.CrossRefGoogle Scholar
National Institute on Drug Abuse 2003. Preventing Drug Use among Children and Adolescents: A Research-Based Guide for Parents, Educators and Community Leaders. Second edition, National Institute on Drug Abuse, Bethesda, Maryland.Google Scholar
National Treatment Agency for Substance Misuse 2002. Models of Care for Substance Misuse. National Treatment Agency for Substance Misuse, London.Google Scholar
Parker, H., Newcombe, R. and Bakx, K. 1987. The new heroin users: prevalence and characteristics in Wirral, Merseyside. British Journal of Addiction, 82, 2, 147–57.CrossRefGoogle ScholarPubMed
Roe, S. 2005. Drug Misuse Declared: Findings from the 2004/05 British Crime Survey. Home Office, London.Google Scholar
Rosen, D. 2004. Factors associated with illegal drug use among older methadone clients. The Gerontologist, 44, 4, 543–7.CrossRefGoogle ScholarPubMed
Sondhi, A., O'Shea, J. and Williams, T. 2002. Emerging Findings from the National Arrest Referral Monitoring and Evaluation Programme. DPAS Paper 18, Home Office, London.Google Scholar
SPSS Inc. 1999. SPSS Base 10.0 for Windows Users' Guide. SPSS, Chicago.Google Scholar
Weintraub, E., Weintraub, D., Dixon, L., Delahanty, J., Gandhi, D., Cohen, A. and Hirsch, M. 2002. Geriatric patients on a substance abuse consultation service. American Journal of Geriatric Psychiatry, 10, 3, 337–42.CrossRefGoogle ScholarPubMed
Ziere, G., Dieleman, J. P., Hofman, A., Pols, H. A. P., van der Cammen, T. J. M. and Stricker, B. H. C. H. 2005. Polypharmacy and falls in the middle age and elderly population. British Journal of Clinical Pharmacology, 61, 2, 218–23.CrossRefGoogle Scholar